Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Blood Advances|September 11, 2023
Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphomaIvana Spasevska, Ankush Sharma, Chloé B Steen, et al.
Leukemia & Lymphoma|March 11, 2017
Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemiaFie J Vojdeman, Sarah E M Herman, Nikolai Kirkby, et al.
Blood|May 19, 2019
Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapyEmanuele Zucca, Stephanie Rondeau, Anna Vanazzi, et al.
Haematologica|April 16, 2017
Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker ConsortiumWendy B C Stevens, Matias Mendeville, Robert Redd, et al.
British Journal of Haematology|July 6, 2016
15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateauChristian W Eskelund, Arne Kolstad, Mats Jerkeman, et al.
The Lancet. Haematology|August 7, 2018
Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysisMassimo Federico, María Dolores Caballero Barrigón, Luigi Marcheselli, et al.
Blood|March 22, 2014
Nordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphomaArne Kolstad, Anna Laurell, Mats Jerkeman, et al.
Haematologica|January 18, 2015
Ofatumumab in poor-prognosis chronic lymphocytic leukemia: a phase IV, non-interventional, observational study from the European Research Initiative on Chronic Lymphocytic LeukemiaCarol Moreno, Marco Montillo, Panayiotis Panayiotidis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2019
Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker ConsortiumAndreas Rosenwald, Susanne Bens, Ranjana Advani, et al.
Blood Advances|July 11, 2022
Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IVG Tjitske Los-de Vries, Wendy B C Stevens, Erik van Dijk, et al.
Pageof 12